This evaluation can determine whether juvenile animal studies are warranted and, if warranted, their timing in relation to clinical trials.〔【出典】ICHガイドライン 〕
しかし、当該医薬品の対象として小児を組み入れるために幼若動物を用いた試験を追加する必要はない。
Studies in juvenile animals are not usually conducted in order to support inclusion of pediatric populations for the treatment of cancer.〔【出典】ICHガイドライン 〕
Conduct of studies in juvenile animals should be considered only when human safety data and previous animal studies are considered insufficient for a safety evaluation in the intended pediatric age group.〔【出典】ICHガイドライン 〕
Generally, juvenile animal toxicity studies are not considered important for short-term PK studies (e.g., 1 to 3 doses) in pediatric populations.〔【出典】ICHガイドライン 〕
The conduct of any juvenile animal toxicity studies should be considered only when previous animal data and human safety data, including effects from other drugs of the pharmacological class, are judged to be insufficient to support pediatric studies.〔【出典】ICHガイドライン 〕
Depending on the therapeutic indication, age of the pediatric population, and safety data from adult animal and human exposure, the appropriateness of obtaining juvenile animal study results before initiation of short-duration multiple-dose efficacy and safety trials should be considered.〔【出典】ICHガイドライン 〕
For long-term clinical trials in pediatric populations when an assessment of juvenile animal toxicity is recommended, the nonclinical studies should be completed before the initiation of the trials.〔【出典】ICHガイドライン 〕